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HDLa b s t r a c t
Background: Coronary artery disease (CAD) is emerging as a major health problem in India. It is predicted
that by 2020, India will be at the verge of CAD epidemic. A low level of high-density lipoproteins (HDL) is
prevalent in Asian Indians and is the major lipid risk factor for CAD. HDL contains Apo A, E, C and antiox-
idant enzymes. The genetic variants of these proteins appear to influence the occurrence and frequency of
CAD. In this context APO A4 have drawn much attention. The polymorphisms at Thr347Ser and
Gln360His of the apo A4 gene are under investigation in different parts of the world in relation to dys-
lipidemias, diabetes and CAD. Since data are conflicting and no conclusive data is available from India.
Objective: We aimed at studying the relationship between apoA4 gene polymorphisms (Thr347Ser and
Gln360His) and coronary artery disease in northern Indian participants.
Method: We recruited 200 control (Group-I) and 200 patients (Group-II) and used PCR-RFLP to study the
gene polymorphisms. Enzymatic Kits were used to estimate the lipids and lipoproteins.
Result: We observed not any significant association for ApoA4 Thr347Ser polymorphism as well as lipid
profile [total cholesterol (TC), triglyceride (TG), HDL, low-density lipoproteins (LDL) and HDL/LDL] levels
among AA, AT and TT Individuals in controls and patients. However, after adjusting for age and sex,
among control AA genotype had significantly lower levels of oxidised LDL (OXLDL) as compared to AT
genotype and in patients, levels of OXLDL in AT genotype was lower than with AA genotype and for
ApoA4 Gln360His polymorphism, after adjusting for age and sex, and no significant difference was
observed in TC, TG, HDL, LDL and HDL/LDL, OXLDL and LDL / OXLDL levels among 1–1, and 1–2.
Individuals in controls and patients.
Conclusion: To accomplish, this preliminary study brought the information on the ApoA4 polymorphism
in the Asian Indians residing in Delhi and adjacent areas. The minor alleles of the Ser347 and His360
showed significant association with lipid risk factors like high levels of OXLDL, TC, and low HDL levels.
However neither of these polymorphisms showed an association with CAD.
 2017 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The impairment of cardiac function due to inadequate blood
flow to the heart, leads to Coronary artery disease (CAD) [1].
Hypercholesterolemia as well as high level of LDL cholesterol con-
sidered as major risk factors for development and progression of
atherosclerosis [2]. low-density lipoproteins (LDL) driven
atherosclerotic plaque formation result in tissue ischemia and
end organ damage in coronary artery disease [3]. Among Indians,CAD has been found to be severe, diffuse and associated with seri-
ous complications and increased mortality at younger age [4].
Among Asian Indians, Low levels of HDL and hypertriglyceridemia
have emerged as major risk factors for CAD [5]. Genetic factors
such as Cluster of apolipoprotein gene has been identified as a
potential genetic contributing factor for inter-individual differ-
ences in the levels of high-density lipoproteins (HDL) cholesterol
and triglyceride (TG) and predisposition to cardiovascular diseases
[6].
ApoA4 has been known to play a major role in lipid metabolism
at several steps of reverse cholesterol transport [7] and acting as
potent inhibitor of lipid peroxidation and thus provides protection
against the risk of atherosclerosis [8]. ApoA4 gene is polymorphic
at codons 127, 130, 347 and 360 [9] and most commonly studied
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demias are apoA4-347 and apoA4-360 [10]. The association of
apoA4 Thr347Ser with coronary artery disease and other cardio-
vascular disease had been studied in different population [6,11].
ApoA4 is a polymorphic gene and this polymorphism arises due
to a substitution of base adenine (A) to thymine (T) in the apoA4
gene. Due to this base change the amino acid changes from thre-
onine to serine. Three genotypes are observed. These are AA, AT,
TT. Where AA represents threonine and TT represents serine.
A Polymorphism of Thr347Ser (of apoA4 gene) lowered antiox-
idant status and associated with cardiovascular disease (CVD) [12].
Ser347 allele associated with lower plasma Apo B, Apo A4 level and
LDL-C level, and increased level of LDL [12–15]. A Polymorphism
Gln360His (of apoA4 gene) has been associated with triglycerides
(TG), HDL-C, LDL-C, glucose and ApoA4 level [11,12,16]. However,
polymorphisms apoA4-347 and apoA4-360 have been studied
mostly in Western countries and information as well as contradic-
tory in different population studies. Up till now, study is scanty
from north Indian population.
Hence, the present study was designed to elucidate the relation-
ship of the Thr347Ser and Gln360His polymorphisms with coro-
nary artery disease. Objectives were (I) To study the frequency
distribution of apoA4 Thr347Ser, Gln360His genotype and alleles
in healthy individuals (control) and patients with CAD; (II) To
determine the levels of cholesterol, TG, HDL, LDL and oxidised
LDL in study subjects; (III) To evaluate the correlations of apoA4
Thr347Ser and Gln360His polymorphisms with lipid profiles; and
(IV) To evaluate the correlations of apoA4 Thr347Ser and
Gln360His polymorphisms with CAD.2. Subjects and methods
2.1. Biological reagents
ApoA4 Thr347Ser, Gln360His sense and antisense primers, Hin-
f1, Fnu4HI restriction enzymes, deoxynucleotides, Taq DNA poly-
merase with buffers and DNA markers were purchased from
Promega Corporation, USA. Proteinase K was obtained from Ban-
glore Genei.
2.2. Ethnic statement
The study was approved by ethical committee and the research
advisory committee of All India Institute of Medical Science and
Hospital. The present study was conducted in the Department of
Biochemistry, All India Institute of Medical Science, Delhi, India.
The work was carried out in accordance with the Code of Ethics
of the World Medical Association (Declaration of Helsinki).
Detailed written consent of all the participants was taken and
the purpose of study was explained to the participants and assur-
ance was given to the participants that test is not hurtful.
2.3. Participants
2.3.1. Inclusion and exclusion criteria
Participants meeting the following criteria were included: All
patients were assessed angiographically, patients with  70%
diameter stenosis in  1 coronary artery involvement, and
Age > 40 years, and patients with other complication such as dia-
betes and hypertension were included and, patients with < 70%
Stenosis, Cardiomyopathy and Drugs abusers were excluded. For
Healthy individuals, subjects free from clinical diagnosis for any
major chronic or acute illness were included and individuals
age < 40 years and pregnant women were excluded. Finally, all
selected participants were divided randomly into the followinggroups, Group I-(n = 200)-normal healthy individual and the study
group were patients suffering with CAD in Group II (n = 200).2.3.2. Sample collection, processing and storage
Under aseptic conditions, venous blood (5 ml) was collected in
EDTA and serum tube, from each participant after overnight fast-
ing. Plasma was separated by centrifugation at 4 C, and store at
70 C until further analysis. The packed cells were processed for
DNA isolation. Clotted blood was allowed to centrifuge at
2000 rpm for 10 min and separated serum was stored at 4 C until
further analysis.2.4. Protocol
2.4.1. DNA analysis by PCR-RFLP for elucidating Apo A4 T347S and
G360H polymorphisms
Gnomic DNA samples were isolated from the leukocyte of blood
samples. RBC was lysed using RBC lysis buffers (Tris, Mgcl2, Nacl,
pH 7.6). The DNA from leukocytes was extracted by proteinase K
digestion and ethanol extraction. The genomic DNA was amplified
by polymerase chain reaction (PCR) using primers of ApoA4 gene.
Primer pairs were used: [sense- 50- CGGGT GGAGCCCTACGGGGA-
30] and [antisense- 50- TGGGGCCAGTGCACCAGGGG-3]0 (Boerwin-
kle et al. [17], Zaiou et al. [18]). DNA was initially denatured for
4 min at 94 C, followed by 35 cycles at 94 C for 30 s and 65 C
for 75 s and then finally at 65 C for 10 min. Amplified products
were run on a check gel with 0.8% agarose. The amplified product
was 300 bp. For Thr347Ser polymorphism the amplified product
was digested with HinfI which gave rise to 183 bp and 117 bp band
in homozygous allele (+/+) where as in homozygous rare allele
(/) site for HinfI get lost so it gives only 300 bp band. In
heterozygous stateb (+/) it gives all the three bands of 300 bp,
183 bp and 117 bp. For Gln360His polymorphism amplified pro-
duct was digested with Fnu4HI it gave rise to 180 bp, 65 bp,
43 bp and 12 bp band in homozygous allele (+/+). Whereas in
homozygous rare allele site for one site of Fnu4HI get lost which
give rise to 192 bp, 65 bp and 43 bp. In heterozygous state it gives
all the five band of size 192 bp, 180 bp, 65 bp, 43 bp and 12 bp
(+/). Digested PCR fragment was visualised using silver staining.2.4.2. Analysis of lipid profile
Triglycerides and Cholesterol estimation was done by enzy-
matic kit method (Centronic GmbH); HDL cholesterol estimation
was done byWilson and Spiger method, LDL cholesterol was calcu-
lated by = Total cholesterol – TG/5-HDL cholesterol, and oxidised
LDL (OXLDL) was estimated by ELISA kit method (Mercodia).2.5. Statistical methods
Statistical methods were done according to Statistical Methods
for Medical Research using SPSS-9 software programme. Frequency
of genotypes (AA, AT, TT) and alleles (A, T) of Thr347Ser and (1–1,
1–2, 2–2) and alleles (1, 2) of Gln360His of apoA4 gene were
assessed using Fisher’s exact test and chi-square. The statistical
analysis was performed by student t test or Mann-Whitney test
as relevant. P  0.05 was considered statistically significant.3. Result
3.1. The identification of apoA4 Thr347Ser alleles and genotypes
The Fig. 1 represents the PCR product of apoA4 gene of 300 bp.
After digestion with Hinf1 the resulting fragments [AA(lane2)
= 183 bp; 117 bp, AT(lane3) = 300 bp; 183 bp; 117 bp and TT







Fig. 1. Agrose-gel electrophoresis of PCR product: The representative agrose gel
shows a band of 300 bp in lane 1,2,3,4 and 5. Lane 6 is the negative control of PCR,
lane 7 represents the DNA ladder.
Table 1
ApoA4Thr347Ser polymorphism: Frequency of AA, AT and TT genotypes, A & T allele
in controls and CAD patient.
Genotype Codon 347 No. observed % Allele frequency
Control
AA 166 83 A = 0.91
AT 33 16.5
TT 1 0.5 T = 0.087
CAD Patients
AA 163 81.5 A = 0.91
AT 35 17.5
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Fig. 3. PAGE gel electrophoresis of DNA: Representative gel of digested PCR product
by Fnu4HI for analysis of apoA4 Gln360His polymorphism. Lane1 (1–2), lane5, 6, 7,
8, 9 (1–1), lane3 was control and lane2, 4 were Ladder respectively.
Table 2
Distribution of genotypes (1–1, 1–2 &2–2) and allele (1 & 2) in normal control and
CAD patient.
Genotype Codon 360 No. observed % Allele frequency
Control
1–1 190 95.00 1 = 0.975
1–2 10 5.00
2–2 0 2 = 0.025
CAD Patients
1–1 196 98.00 1 = 0.99
1–2 4 2.00
2–2 0 2 = 0.01
#1-Glutamine, 1–2-Glutamine-Histidine, 2-Histidine.
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visualised by silver staining (Fig. 2).
3.2. Frequency distribution of apoA4 Thr347Ser polymorphism in
normal controls and CAD patients
The data are summarized in (Table 1): Among normal controls
(n = 200) genotype AA was 83%, AT + TT was 17%. Allelic frequen-
cies were 0.91 and 0.087 for A and T respectively in controls.
Among CAD patients (n = 200) genotype AA was 81.50%, AT+TT
was 18.50%. While the allelic frequencies were 0.91 and 0.088 for
A and T. The frequency of T allele is 1%higher in CAD patients than
healthy volunteers. The AT + TT was 1.5% higher in CAD patients
than controls.
3.3. The identification of apoA4 Gln360His allele and genotypes
The Fig. 1 represents the PCR product of apoA4 gene of 300 bp.
After digestion with Fnu4HI the resulting fragments [1–1
(lane5,6,7,8,9)=180 bp;65 bp;43 bp;12 bp, 1–2(lane1)=192 bp;
180 bp; 65 bp;43 bp;12 bp and 2–2 = 192 bp;65 bp;43 bp) were
separated on 12% polyacrylamide gel visualised by silver staining
as shown in (Fig. 3).
3.4. Frequency distribution of apoA4 Gln360His polymorphism in
normal control and CAD patients
The data are summarized in (Table 2): Among normal controls
(n = 200) genotype 1–1 was 95%, 1–2 was 5%. Allelic frequencies
were 0.975 and 0.025 for 1 and 2 respectively in controls. Among
CAD patients 1–1 was 98%, 1–2 was 2% and allelic frequencies were
0.99 and 0.01for 1 and 2.250bp 
Fig. 2. PAGE gel electrophoresis of DNA: Representative gel of digested PCR product
by HinfI for analysis of apoA4 Thr347Ser polymorphism. Lane 1 DNA Ladder (100–
500), lane 2,3and 4 are AA, AT and TT genotypes respectively. Undigested 300 bp
represents T allele. The A allele is represented by two fragments of 183 bp & 117 bp.3.5. Comparison of lipid profiles between controls and patients
The data are summarized in (Table 3, Fig. 4): Mean levels of var-
ious lipids are summarized in angiographically proven CAD
patients and controls. The levels of total cholesterol (TC) were
6.68% lower in the patients (166.93 ± 55.74) as compared to the
controls (178.89 ± 42.92) which was statistically significant
(P = 0.01). The levels of TG were 15.30% lower in patients
(142.49 ± 74.58) as compared to controls (168.23 ± 76.90) whichTable 3
The profiles of lipids and lipoproteins in patients and controls.
Patient Controls P value
TC 166.93 ± 55.74 178.89 ± 42.92 0.016
TG 142.49 ± 74.58 168.23 ± 76.90 0.001
HDL 36.49 ± 11.38 45.72 ± 10.78 0.001
LDL 103.12 ± 56.84 102.80 ± 38.81 0.15
OXLDL 35.92 ± 18.93 39.90 ± 22.79 0.13
HLD/LDL .49 ± .35 .52 ± .28 0.006












Fig. 4. Comparison of lipid profiles between patients and controls. X-axis shows the
lipid parameters, The Y-axis shows the values in (%.). The values for controls were
considered as 100%.
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20.18% lower in the patients (36.49 ± 11.38) as compared to the
controls (45.72 ± 10.78) which was statistically significant
(P = 0.001). The levels of LDL were comparable (P = 0.15) between
patients (103.12 ± 56.84) and the controls (102.80 ± 38.81). The
levels of OXLDL were 11% lower in the patients (35.92 ± 18.93) as
compared to the controls (39.90 ± 22.79) which was statistically
non-significant (P = 0.13). The ratio of HDL/LDL were 6.12% lower
in the patients (0.49 ± 0.35) as compared to the controls
(.52 ± .28) which was statistically significant (P = 0.006). The ratio
of LDL/OXLDL were comparable between patients (3.21 ± 1.9) and
controls (3.2 ± 1.8) which was statistically non-significant
(P = 0.57).3.6. Intergenotypic variation in the levels of lipids, and lipoproteins
among angiographically proven CAD patients and controls with
respect to apoA4 Thr347Ser polymorphism
The data are summarized in (Table 4). After adjusting for age
and sex, no significant difference was observed in TC, TG, HDL,
LDL and HDL/LDL levels among AA, AT and TT Individuals inTable 4
Levels of lipids and lipoproteins in the patients and controls in AA, AT and TT genotypes.
Parameters Groups AA AT
TC Controls 181.02 ± 41.92 168.5 ± 46.75
Patients 167.60 ± 57.80 163.97 ± 46.1
TG Controls 170.57 ± 79.72 156.79 ± 61.0
Patients 167.60 ± 57.80 163.97 ± 46.1
HDL Controls 45.88 ± 10.7 44.94 ± 11.03
Patients 36.28 ± 11.17 37.40 ± 12.38
LDL Controls 104.52 ± 38.04 94.41 ± 41.95
Patients 104.20 ± 58.59 98.32 ± 48.79
OXLDL Controls 37.54 ± 20.49 49.85 ± 29.03
Patients 36.29 ± 17.86 34.27 ± 23.31
HDL/LDL Controls 0.51 ± .27 0.57 ± .31
Patients 0.48 ± .34 0.52 ± .38
LDL/OXLDL Controls 3.42 ± 1.9 2.37 ± 1.3
Patients 3.17 ± 1.86 3.38 ± 2.12
OX-LDL levels expressed in U/L, All other parameters expressed in mg/dl.controls and patients. However, AA genotype had significantly
lower levels of as compared to AT genotype in controls (P = 0.009)
and lower levels of OXLDL in AT genotype as compare to AA geno-
type (P = 0.64) in patients. Significance difference was not observed
in AA and AT genotypes. Conversely AA genotype had significantly
higher levels of as compared to AT genotype in controls (P = .006)
and no significant difference observed in patients.
3.7. Intergenotypic variation in lipids, and lipoprotein among
angiographically proven CAD patients and controls with respect to
apoA4 Gln360His polymorphism
The data are summarized in (Table 5). After adjusting for age
and sex, no significant difference was observed in TC, TG, HDL,
LDL and HDL/LDL, OXLDL and LDL / OXLDL levels among 1–1,
and 1–2. Individuals in controls and patients.4. Discussion
This study was designed to get base line data on apoA4 poly-
morphism at codon 347 and 360 and to gain insight into its possi-
ble association with coronary artery disease and their relationship
with lipid profiles and apoA4 gene.
4.1. The frequency distribution of apoA4 Thr347Ser polymorphism and
its relationship with CAD
ApoA4 is a polymorphic gene and polymorphic site 347 is pre-
sent at the 3rd exon [17]. The alleles (A and T) can be elucidated by
PCR-RFLP using Hinf1 restriction enzyme at the 347 position. The
PCR product of apoA4 gene was 300 bp. When digested with Hinf1
183 bp, 117 bp in homozygous state (AA), 300 bp, 183 bp and
117 bp in heterozygous state (AT) and 300 bp in rare homozygous
state (TT) were observed.
Our study showed that in healthy controls, the frequency distri-
bution of genotypes AA, AT and TT were 83%, 16.5% and 0.5% .The
allele frequency for A and T allele was 0.91 and 0.087 respectively.
The study population belonged to the northern plains of India, the
residents of Delhi and surrounding area. These people generally are
categorized as Indo-Aryans and were homogenous in terms of geo-
graphical distribution, dietary habits and socioeconomic status. A
pure ethnicity is not being claimed as there had been huge admix-
ture of different ethnicity throughout all the regions in India
excepting the tribal belts. The observed distribution pattern in this
study had been similar to that reported for French [18], JapaneseTT Un-adjusted P-value Adjusted P-value
122 0.12 0.06
194.5 ± 46.11 0.72 0.65
223 0.66 0.27
113 ± 1.41 0.21 0.86
48 0.64 0.49
42.5 ± 2.21 0.59 0.72
29 0.14 0.15
129.5 ± 48.79 0.85 0.52
16.7 0.033 0.009
27.6 ± 1.9 0.09 0.64
1.65 0.23 0.30
0.35 ± .15 0.72 0.51
1.7 0.008 0.006
4.76 ± 2.1 0.52 0.70
Table 5
Levels of lipids and lipoproteins in patients and controls in 1–1, 1–2, and 2–2 genotypes.
Parameters Groups 1–1 1–2 2–b Un-adjusted P value Adjusted P value
TC Controls 179.04 ± 43.14 176 ± 40.49 0 0.82 0.45
Patients 166.62 ± 55.91 182 ± 50.61 0 0.58 0.45
TG Controls 168.07 ± 77.06 171.1 ± 77.79 0 0.89 0.87
Patients 142.16 ± 74.96 158.75 ± 58.30 0 0.41 0.57
HDL Controls 45.93 ± 10.85 41.7 ± 8.81 0 0.22 0.16
Patients 36.34 ± 11.28 43.75 ± 15.90 0 0.19 0.13
LDL Controls 102.68 ± 39.02 105 ± 36.42 0 0.63 0.62
Patients 103.09 ± 56.76 104.5 ± 69.82 0 0.94 0.83
OXLDL Controls 39.24 ± 22.15 49.19 ± 30.38 0 0.21 .089
Patients 35.76 ± 19.03 43.47 ± 13.18 0 0.17 0.49
HDL/LDL Controls 0.53 ± 0.28 0.47 ± .33 0 0.78 0.37
Patients 0.48 ± .34 0.69 ± 0.70 0 0.78 0.31
LDL/OXLDL Controls 3.2 ± 1.9 2.67 ± 1.34 0 0.49 0.24
Patients 3.2 ± 1.91 2.36 ± 1.3 0 0.36 0.52
OX-LDL levels expressed in U/L. All other parameters expressed in mg/dl.
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quency of wild genotype was somewhat higher in our population
with corresponding decline in frequency of AT and TT genotype.
ApoA4 Thr347Ser alone was associated with a significant indepen-
dent effect on risk of coronary heart disease in healthy UK popula-
tion; men homozygous for Ser347 had a 2-fold risk compared to
Thr347 homozygotes [11]. Individuals homozygous for the
Ser347 allele had reduced protection against free radical attack
by reactive oxygen species (ROS) [11]. In our study, patients AA,
AT and TT genotype was 81.5%, 17.5% and 1% with frequency of A
and T allele being 0.91 and 0.008. Hardy -Weinberg equation could
not be applied in apoA4 Thr347Ser for our study since out of 200
samples TT genotype is 1 in control and 2 in patients. The fre-
quency of AT + TT combined however was 1.5% higher in patients
as compared to controls.4.2. The frequency distribution of apoA4 Gln360His polymorphism and
its relationship with CAD
Gln360His polymorphism is present at 3rd exon in ApoA4 poly-
morphic gene and it arises due to substitution of the base guanine
to thymine [17]. The amino acid glutamine is replaced by histidine.
Three genotypes were 1–1, 1–2 and 2–2. Allele 1 represents Gln
and 2 represent His. The alleles (1 and 2) elucidated by PCR-RFLP
using Fnu4HI restrictions enzyme at 360 positions. The PCR pro-
duct was 300 bp. When digested with Fnu4HI they formed
180 bp, 65 bp, 43 bp and 12 bp in homozygous state (1–1),
192 bp, 180 bp, 65 bp, 43 bp and 12 bp in heterozygous state (1–
2) and 192 bp, 65 bp and 43 bp in rare homozygous state (2–2).
Our study showed frequency distribution of genotypes 1–1, 1–2
and 2–2 as 95% and 5% and 0% with alleles frequency’10 and’ 20
as 0.975 and 0.025 in the healthy controls. These controls were
the same as described in previous section. The distribution pattern
observed in this study is similar to that reported in previous report
for French[18], Japanese [19], Americans Indians [21], Greek [20]
and USA [22] populations. However the frequency of wild geno-
type (1–1) was higher in our population with corresponding
decline in 1–2 genotypes. The ApoA4 His 360 allele was associated
with myocardial infarction in diabetes patients [23]. This associa-
tion of the His360 allele with type2 diabetes was explained as to
be due to delayed postprandial triglycerides clearance and high
glucose levels [24,25]. ApoA4-2 allele was associated with signifi-
cantly higher risk of Coronary artery calcification progression
among patients with type 1 diabetes [22]. The allele frequency of
less common ApoA4 His360 was in the offspring of fathers withdocumented premature myocardial infarction [24]. This study 1–
1, 1–2 and 2–2 genotypes in patients were distributed as 98%, 2%
and 0% with frequency of ‘1’ and ‘2’ alleless being 0.99 and 0.01.
Hardy-Weinberg equation could also not be applied in ApoA4
His360 for our study because since there is no 2–2 genotype found
in our study in controls as well as in patients. The frequency of 1–2
genotypes is 3% higher in controls than patients. However with
limited sample size in view of very one frequency of the 2 allele
no significance can be ascribed to this observation.4.3. Lipid risk factors
ApoA4 plays a major role in metabolism of TC, triglycerides,
HDL and LDL [26]. The levels of TC were significantly (p = 0.016)
higher in the controls (178.89 ± 42.92) than patients
(166.93 ± 55.74). The levels of TG were higher in controls
(168.23 ± 76.90) than the patients (142.49 ± 74.58) (p = 0.001).
This observation was similar to that earlier published report from
northern India [27]. The most recognized atheroprotective function
of HDL-C is to reverse cholesterol transport [28]. We observed low
levels of HDL-c in patients with CAD (36.49 ± 11.38) (P = 0.001)
when compared to control (45.72 ± 10.78). Low levels of HDL
cholesterol are associated with increased risk of CAD, and this rela-
tionship remains after correction for obesity, age, blood pressure,
total cholesterol, or LDL cholesterol levels [29]. Low HDL choles-
terol is the strongest predictor of subsequent cardiovascular events
in patients with angiographically proven CAD and desirable levels
of total cholesterol [30]. Intrinsically, Asian Indians are predis-
posed to low HDL levels [31]. Thus, low levels of HDL-C may be
the principal factor that accounts for the higher susceptibility of
Asian Indian to CAD [32]. The levels of LDL are almost similar in
patients and controls. Subsequently ox-LDL is the main culprit in
atherogenesis, hence we measure the levels of ox-LDL in patients
and controls which was almost similar and insignificant. The ratio
between the HDL-C and LDL-C levels is considered as a better mar-
ker [33]. The ratio of HDL-C and LDL-C in our study was higher and
significant (p = 0.006) for controls as compared to patients. The
ratio of LDL/OXLDL was similar between controls and patients.4.4. Relationship of the ApoA4 gene polymorphism with lipids and
lipoproteins profiles at codon 347 position
Usually genetic variation at codon 347 on lipid and lipoprotein
plasma levels is inconsistent. Previous studies found no association
of apoA4 A347 T polymorphism on serum lipid, lipoprotein and
28 P. Kumar et al. / The Egyptian Journal of Medical Human Genetics 19 (2018) 23–29apolipoprotein levels when carried out in Greek population [20],
Japanese population [19] and among Finnish and French [34,35].
However, Ser347 allele T was associated with increased LDL con-
centration in Spanish population [36]. T allele was associated with
increased risk of CHD and reduced plasma apoA4 levels [11]. Study
in German population showed that Ser347 allele is associated
lower plasma apoB levels in both sexes and lower LDL levels in
men [37], but no association was found.
4.5. Relationship of the ApoA4 gene polymorphism with lipids and
lipoproteins profiles at codon 360 position
We didn’t observe any association between allele 1 and 2 and
different lipid parameters. A previous study carried out in Japanese
population found no association of apoA4 Gln360His polymor-
phism with serum lipid, lipoprotein and apolipoprotein levels
[19]. A study in Caucasian population in the Famingham offspring
could not show any effect of the ApoA4-2 genotype on plasma TC,
TG and LDL particle size in either men or women [24]. No associa-
tion was observed between the codon 360 polymorphism and total
cholesterol or triglycerides levels in Spanish population [36]. How-
ever, some study had found association, such as among coronary
heart disease patients; the codon 360 polymorphism has shown
to effect plasma Lipid levels and fibrin products [37]. A signifi-
cantly lower triglycerides level was observed in carrier of the
apoA4 His360allele than carrier of the wild type gene in a group
of hyperlipidemic Greek patients [20]. Essentially, this study on
apoA4 Thr347Ser and Gln360His (1–2) polymorphisms similar to
that reported for French [35], Japanese [19], Caucasians
[17,34,38,39] and Greek populations with higher frequency of AA
and 1–1 respectively[20].
5. Conclusion
We conclude that apoA4 Thr347Ser and Gln360His (1–2) poly-
morphisms in people of Asian Indian ethnicity residing at Delhi
and surrounding areas found normal distribution of apoA4
Thr347Ser and apoA4 Gln360His polymorphisms, and no associa-
tion of these polymorphisms with CAD could be established. How-
ever there had been a significant association of T allele (AT + TT)
genotype of the apoA4 Ser347 polymorphismwith lipid risk factors
like OXLDL and LDL/OXLDL in controls but not in patients. The rea-
son is unclear at present.
6. Limitation
However to ascribe a statistical significance to this observation
a much larger number of samples need to be studied.
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